| __timestamp | Regeneron Pharmaceuticals, Inc. | Telix Pharmaceuticals Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 205018000 | 22622695 |
| Thursday, January 1, 2015 | 392709000 | 24863028 |
| Friday, January 1, 2016 | 299694000 | 21351001 |
| Sunday, January 1, 2017 | 397061000 | 53837297 |
| Monday, January 1, 2018 | 434100000 | 16080096 |
| Tuesday, January 1, 2019 | 782200000 | 18525736 |
| Wednesday, January 1, 2020 | 1119900000 | 2024000 |
| Friday, January 1, 2021 | 2437500000 | 2548000 |
| Saturday, January 1, 2022 | 1560400000 | 61556000 |
| Sunday, January 1, 2023 | 1815800000 | 188157000 |
| Monday, January 1, 2024 | 1970500000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis delves into the cost of revenue trends for Regeneron Pharmaceuticals, Inc. and Telix Pharmaceuticals Limited from 2014 to 2023. Regeneron, a leader in biotechnology, has seen its cost of revenue grow by approximately 785% over this period, peaking in 2021. This surge reflects its aggressive expansion and increased production capabilities. In contrast, Telix Pharmaceuticals, a rising star in radiopharmaceuticals, experienced a staggering 730% increase in costs, with a notable spike in 2023. This growth underscores Telix's rapid scaling and market penetration efforts. While Regeneron's costs are significantly higher, Telix's growth trajectory is noteworthy, highlighting its potential in the competitive landscape. This comparative insight offers a window into the strategic financial maneuvers of these pharmaceutical giants.
Comparing Cost of Revenue Efficiency: Merck & Co., Inc. vs Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Pfizer Inc. and Telix Pharmaceuticals Limited
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Vertex Pharmaceuticals Incorporated and Telix Pharmaceuticals Limited
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Evotec SE's Expenses
Cost of Revenue: Key Insights for Insmed Incorporated and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Telix Pharmaceuticals Limited vs ACADIA Pharmaceuticals Inc.